Oppenheimer & CO Inc Sarepta Therapeutics, Inc. Transaction History

Oppenheimer & CO Inc

$6.42 Billion
Q3 2024

A detailed history of Oppenheimer & CO Inc transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Oppenheimer & CO Inc holds 2,250 shares of SRPT stock, worth $267,682. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,250

Previous 2,250 -0.0%

Holding current value

$267,682

Previous $355,000 20.85%

% of portfolio

0.0%

Previous 0.01%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	SELL	$113.33 - $163.85 $158,662 - $229,390	-1,400 Reduced 38.36%	2,250 $355,000
Q1 2024 May 06, 2024	SELL	$93.7 - $141.53 $93 - $141	-1 Reduced 0.03%	3,650 $472,000
Q4 2023 Feb 13, 2024	SELL	$67.31 - $124.76 $269 - $499	-4 Reduced 0.11%	3,651 $352,000
Q2 2023 Aug 02, 2023	BUY	$106.4 - $157.19 $532 - $785	5 Added 0.14%	3,655 $418,000
Q4 2022 Feb 07, 2023	SELL	$100.86 - $132.13 $25,215 - $33,032	-250 Reduced 6.41%	3,650 $472,000
Q3 2022 Nov 14, 2022	SELL	$75.71 - $119.24 $6,359 - $10,016	-84 Reduced 2.11%	3,900 $432,000
Q1 2022 May 12, 2022	SELL	$63.15 - $90.42 $947 - $1,356	-15 Reduced 0.38%	3,984 $312,000
Q4 2021 Feb 02, 2022	BUY	$77.28 - $99.42 $2,086 - $2,684	27 Added 0.68%	3,999 $360,000
Q3 2021 Nov 12, 2021	SELL	$65.97 - $92.48 $5,937 - $8,323	-90 Reduced 2.22%	3,972 $367,000
Q2 2021 Aug 03, 2021	SELL	$69.38 - $86.75 $333,162 - $416,573	-4,802 Reduced 54.17%	4,062 $316,000
Q1 2021 May 10, 2021	BUY	$72.25 - $168.95 $18,785 - $43,927	260 Added 3.02%	8,864 $660,000
Q4 2020 Feb 11, 2021	BUY	$125.56 - $178.74 $36,914 - $52,549	294 Added 3.54%	8,604 $1.47 Million
Q3 2020 Nov 13, 2020	SELL	$127.12 - $172.34 $10,678 - $14,476	-84 Reduced 1.0%	8,310 $1.17 Million
Q2 2020 Aug 11, 2020	BUY	$93.0 - $171.7 $101,091 - $186,637	1,087 Added 14.88%	8,394 $1.35 Million
Q1 2020 May 08, 2020	BUY	$82.38 - $131.64 $25,455 - $40,676	309 Added 4.42%	7,307 $714,000
Q4 2019 Feb 07, 2020	SELL	$76.53 - $135.58 $10,867 - $19,252	-142 Reduced 1.99%	6,998 $903,000
Q3 2019 Oct 31, 2019	SELL	$72.81 - $156.91 $112,345 - $242,112	-1,543 Reduced 17.77%	7,140 $538,000
Q2 2019 Aug 09, 2019	SELL	$112.21 - $151.95 $91,451 - $123,839	-815 Reduced 8.58%	8,683 $1.32 Million
Q1 2019 Apr 24, 2019	SELL	$106.67 - $151.68 $147,524 - $209,773	-1,383 Reduced 12.71%	9,498 $1.13 Million
Q4 2018 Jan 29, 2019	SELL	$97.32 - $148.76 $400,471 - $612,147	-4,115 Reduced 27.44%	10,881 $1.19 Million
Q3 2018 Oct 26, 2018	SELL	$115.31 - $161.51 $58,923 - $82,531	-511 Reduced 3.3%	14,996 $2.42 Million
Q2 2018 Aug 10, 2018	SELL	$71.74 - $153.69 $401,241 - $859,588	-5,593 Reduced 26.51%	15,507 $2.05 Million
Q1 2018 May 01, 2018	SELL	$54.02 - $82.27 $633,654 - $965,027	-11,730 Reduced 35.73%	21,100 $1.56 Million
Q4 2017 Feb 07, 2018	SELL	$47.64 - $56.75 $36,301 - $43,243	-762 Reduced 2.27%	32,830 $1.83 Million
Q3 2017 Nov 09, 2017	BUY	$35.73 - $47.15 $1.2 Million - $1.58 Million	33,592	33,592 $1.52 Million

Others Institutions Holding SRPT

# of Institutions

529

Shares Held

84.2M

Call Options Held

2.06M

Put Options Held

1.52M

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.4B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Oppenheimer & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Oppenheimer & CO Inc with notifications on news.

Account

Oppenheimer & CO Inc Sarepta Therapeutics, Inc. Transaction History